Here, we identify a rare subpopulation of CD44+CD24− prostate cancer cells with stem-like characteristics such as increased clonogenic and tumorigenic properties, and the ability to grow as nonadherent spheres in serum-replacement medium. The gene discussed is CD44; the disease is prostate carcinoma.